Skip to main content
. 2022 Feb 28;12:833478. doi: 10.3389/fonc.2022.833478

Table 1.

Descriptive characteristics before and after propensity score matching.

Characteristic Participants, No. (%)a
Before propensity score matching After propensity score matching
PCI (n = 81) non-PCI (n = 225) p-Value PCI (n = 75) non-PCI (n = 75) p-Value
Age
 <65 years 68 (84.0) 188 (83.6) 0.934 63 (84.0) 64 (85.3) 0.821
 ≥65 years 13 (16.0) 37 (16.4) 12 (16.0) 11 (14.7)
Sex
 Female 26 (32.1) 74 (32.9) 0.897 22 (29.3) 16 (21.3) 0.260
 Male 55 (67.9) 151 (67.1) 53 (70.7) 59 (78.7)
Smoking index
 <400 42 (51.9) 126 (56.0) 0.520 37 (49.3) 30 (40.0) 0.250
 ≥400 39 (48.1) 99 (44.0) 38 (50.7) 45 (60.0)
KPS
 <80 3 (3.7) 14 (6.2) 0.296 3 (4.0) 2 (2.7) 0.500
 ≥80 78 (96.3) 211 (93.8) 72 (96.0) 73 (97.3)
Clinical stage
 I/II 27 (33.3) 46 (20.4) 0.015 23 (30.7) 25 (33.3) 0.726
 III 54 (66.7) 179 (79.6) 52 (69.3) 50 (66.7)
Obstructive pneumonia
 Yes 23 (28.4) 73 (32.4) 0.501 22 (29.3) 24 (32.0) 0.723
 No 58 (71.6) 152 (67.6) 53 (70.7) 51 (68.0)
Initial treatment
 Concurrent CRT 38 (46.9) 52 (23.1) 0.001 35 (46.7) 29 (38.7) 0.322
 Sequential CRT 43 (53.1) 173 (76.9) 40 (53.3) 46 (61.3)
Response to initial treatment
 CR 19 (23.5) 19 (8.4) 0.001 16 (21.3) 8 (10.7) 0.075
 PR/SD 62 (76.5) 206 (91.6) 59 (78.7) 67 (89.3)

PCI, prophylactic cranial irradiation; KPS, Karnofsky Performance Status; CRT, chemoradiotherapy; CR, complete response; PR, partial response; SD, stable disease.

The bold values inidicate p-value is less than 0.05.